6484 Journal of Medicinal Chemistry, 2007, Vol. 50, No. 26
Coelho et al.
K. M.; Schipilowa, S. J.; Nowikowa, N. W.; Rukasenkow, J. E.;
Pomojnezkij, W. D.; Grenadorov, S. J. Action of Nonsteroidal Anti-
Inflammatory Agents of Fibrinolysis and Platelet Aggregation. Folia
Haematol. Int. Klin. Morphol. Blutforcsh. 1986, 113, 230–235.
(5) Kunapuli, S. P.; Ding, Z.; Dorsam, R. T.; Kim, S.; Murugappan, S.;
Quinton, T. M. ADP ReceptorssTargets for Developing Antithrom-
botic Agents. Curr. Pharm. Des. 2003, 9, 2303–2316.
(6) (a) Mousa, S. A.; Bennet, J. S. Platelets in Health and Dissease: Platelet
GPIIb/IIIa Structure and Function: Recent Advances in Antiplatelet
Therapy. Drugs Future 1996, 21, 1141–154. (b) Mousa, S. A.
Antiplatelet Therapies: Platelet GPIIb/IIIa Antagonists and Beyond.
Curr. Pharm. Des. 2003, 9, 2317–2322.
Platelet Aggregation Inhibitors. Bioorg. Med. Chem. Lett. 2002, 10,
1575–1577.
(13) Coelho, A.; Sotelo, E.; Novoa, H.; Peeters, O. M.; Blaton, N.; Raviña,
E. Efficient Heck Alkenylation at Position 5 of the 6-Phenyl-3(2H)-
pyridazinone System. Tetrahedron Lett. 2004, 45, 3459–3463.
(14) (a) Coelho, A.; Sotelo, E.; Novoa, H.; Peeters, O. M.; Blaton, N.; Raviña,
E. Reactivity of 5-Iodopyridazin-3(2H)-ones in Palladium-Catalysed
Reactions. Tetrahedron 2004, 60, 12177–12189. (b) Krajsovszky, G.;
Karolyhazy, L.; Riedl, Zs.; Csampai, A.; Dunkel, P.; Lernyei, A.;
Dajka-Halasz, B.; Hajos, Gy.; Matyus, P. Reaction of Chloropyridazin-
3(2H)-ones with Iodide. Part I. A Mechanistic Study. THEOCHEM
2005, 713, 235–243.
(15) (a) Beletskaya, I. P.; Cheprakov, A. V. The Heck Reaction as a
Sharpening Stone of Palladium Catalysis. Chem. ReV. 2000, 100, 3009–
3066. (b) Brase, S.; de Meijere, A. In Metal-Catalyzed Cross-Coupling
Reactions; Diedrich F., Stang P. J., Eds.; Wiley-VCH: New York,
1998; p 99. (c) Cabri, W.; Candiani, I. Recent Developments and New
Perspectives in the Heck Reaction. Acc. Chem. Res. 1995, 28, 2–7.
(d) de Meijere, A.; Meyer, F. E. Clothes Make the People: The Heck
Reaction in New Clothing. Angew Chem., Int. Ed. 1994, 33, 2379–
2411.
(16) (a) Coelho, A.; Sotelo, E.; Estévez, I.; Raviña, E. Efficient Arylation
at 5 Position of the 6-phenyl-3(2H)-pyridazinone System Using a
Suzuki-Type Cross-Coupling Reaction. Synthesis 2001, 871, 876. (b)
Coelho, A.; Raviña, E.; Sotelo, E. Palladium-Catalysed Synthesis of
6-Phenyl-5-substituted-3(2H)-pyridazinones Assisted by a Retro-Ene
Transformation. Synlett 2002, 6062–6064. (c) Coelho, A.; Sotelo, E.;
Raviña, E. Sonogashira Approaches in the Synthesis of 5-Substituted-
6-phenyl-3(2H)-pyridazinones. Tetrahedron 2003, 59, 2477–2484. (d)
Sotelo, E.; Coelho, A.; Raviña, E. Stille-Based Approaches in the
Synthesis of 6-Phenyl-5-Substituted-3(2H)-pyridazinones. Chem. Pharm.
Bull. 2003, 51, 427–430.
(17) Born, G. V. R. Aggregation of Blood Platelets by Adenosine
Diphosphate (ADP) and Its Reversal. Nature 1962, 194, 927–929.
(18) (a) Sugimoto, A.; Tanaka, H.; Eguchi, Y.; Ito, S.; Takashima, Y.;
Ishikawa, M. 7-(Ethoxycarbonyl)-6,8-dimethyl-2-phenyl-1(2H)-ph-
thalazinone Derivatives: Synthesis and Inhibitory Effects on Platelet
Aggregation. J. Med. Chem. 1984, 27, 1300–1305. (b) Ohi, N.; Kuroki,
T.; Yamaguchi, M.; Akima, M.; Koga, T.; Kamei, K. Preparation of
Fused Pyridazine Derivatives as Thromboxane A2 (TXA2) Synthetase
Inhibitors. PCT Int. Appl. WO9112251 A119910822, 1991.
(19) Crespo, A.; Meyers, C.; Coelho, A.; Yáñez, M.; Fraiz, N.; Sotelo, E.;
Maes, B. U. W.; Laguna, R.; Cano, E.; Raviña, E. Synthesis,
Antiplatelet Activity and SAR of 2,4,6-Substituted 5-(3-Oxo-3-
phenylprop-1-en-1-yl)- or 5-(3-Phenylprop-2-enoyl)pyridazin-3(2H)-
ones. Bioorg. Med. Chem. Lett. 2006, 16, 1080–1083.
(7) Mousa, S. A. Antiplatelets Therapies: From Aspirin to GP IIb/IIIa
Receptor Antagonists and Beyond. Drug DiscoVery Today 1999, 4,
552–561.
(8) (a) Alousi, A. A.; Johnson, D. C. Pharmacology of the Bipyridines:
Amrinone and Milrinone. Circulation 1986, 73, III10–III24. (b) Alousi,
A. A.; Farah, A. E. Amrinone: A New Oral and Parenteral Cardiotonic
Agent. Trends Pharmacol. Sci. 1980, 1, 143–146. (c) Farah, A. E.;
Alousi, A. A. New Cardiotonic Agents: A Search for Digitalis
Substitute. Life Sci. 1978, 22, 1139–1147. (d) Alousi, A. A.; Walton,
L. H.; Lesher, G. Y.; Farah, A. E. The Cardiac Bipyridines. A New
Chemical Entity with Distinct Positive Inotropic and Vasodilatory
Activity. R. Soc. Chem. 1984, 50, 65–81.
(9) (a) Schudt, C.; Winder, S.; Mueller, B.; Ukena, D. Zardaverine as a
Selective Inhibitor of Phosphodiesterase Isozymes. Biochem. Phar-
macol. 1991, 42, 153–162. (b) Saniabadi, A. R.; Lowe, G. D.; Belch,
J. J.; Forbes, C. D. Platelet Aggregation Inhibitory Effects of the New
Positive Inotropic Agents Pimobendan and UD CG 212 in Whole
Blood. CardioVasc. Res. 1989, 23, 184–190. (c) Corsano, S.; Vezza,
R.; Scapicchi, R.; Foresi, S.; Strappaghetti, G.; Nenci, G. G.; Gresele,
P. New Pyridazinone Derivatives as Inhibitors of Platelet Aggregation.
Eur. J. Med. Chem. 1995, 30, 627–631. (d) Cignarella, G.; Barlocco,
D.; Pinna, G. A.; Loriga, M.; Tofanetti, O.; Germini, M.; Sala, F.
Conformationally Restricted Congeners of Hypotensive and Platelet
Aggregation Inhibitors: 6-Aryl-5-methyl-4,5-dihydro-3(2H)-pyridazi-
nones derived from 5H-indeno[1,2-c]pyridazine. J. Med. Chem. 1986,
29, 2191–2194. (e) Cignarella, G.; Barlocco, D.; Pinna, G. A.; Loriga,
M.; Curzu, M. M.; Tofanetti, O.; Germini, M.; Cazzulani, P.; Cavalletti,
E. Synthesis and Biological Evaluation of Substituted Benzo[h]cin-
nolinones and 3H-benzo[6,7]cyclohepta[1,2-c]pyridazinones: Higher
Homologs of the Antihypertensive and Antithrombotic 5H-indeno[1,2-
c]pyridazinones. J. Med. Chem. 1989, 32, 2277–2282.
(10) Estévez, I., Synthesis and Evaluation of 6-Arylpyridazine Derivatives
as Platelet Aggregation Inhibitors and Vasodilator Agents. Ph.D.
Thesis, Universidad de Santiago de Compostela, Spain, 1995.
(11) (a) Montero-Lastres, A.; Fraiz, N.; Laguna, R.; Cano, E.; Estévez, I.;
Raviña, E. 6-Aryl-3(2H)-pyridazinones Inhibit Calcium Influx in
Stimulated Platelets. Biol. Pharm. Bull. 1999, 22, 1376–1379. (b)
Sotelo, E.; Fraiz, N.; Yañez, M.; Terrades, V.; Laguna, R.; Cano, E.;
Raviña, E. Synthesis and Platelet Aggregation Inhibition Activity of
5-Substituted-6-phenyl-3(2H)-pyridazinones. Novel Aspects of their
Biological Actions. Bioorg. Med. Chem. 2002, 10, 2873–2882.
(12) Sotelo, E.; Fraiz, N.; Yañez, M.; Laguna, R.; Cano, E.; Brea, J.; Raviña,
E. 5-Alkylidene-6-phenyl-3(2H)-pyridazinones, a New Family of
(20) The calculated values of log P (clogP, Figure 8) were obtained
istry.org/prog/peo/).
(21) Dal Piaz, V.; Giovannoni, M. P.; Castellana, C.; Palacios, J. M.; Beleta,
J.; Doménech, T.; Segarra, V. Heterocyclic-Fused 3(2H)-Pyridazinones
as Potent and Selective PDE IV Inhibitors: Further Structure-Activity
Relationships and Molecular Modelling Studies. Eur. J. Med. Chem.
1998, 33, 789–797.
JM061401D